Kura Oncology (KURA) Selling, General & Administrative (2009 - 2026)
Kura Oncology (KURA) recorded Selling, General & Administrative of $31.75 million in Q2 2026, up 26.1% from $25.17 million a year earlier and up 0.6% from the prior quarter.
Powered by 
Analysis
Kura Oncology (KURA) Selling, General & Administrative (2009 - 2026) Analysis & Trends
On a TTM basis, Kura Oncology's Selling, General & Administrative came in at $111.31 million as of Jun 30, 2026, up 23.3% year-over-year; for FY2025, it came in at $119.98 million, up 55.6% from FY2024.
- Annual Selling, General & Administrative has increased for eight straight years, with a five-year compound annual growth rate of 30.7% (FY2020 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $77.11 million in FY2024 (+52.5%), $50.57 million in FY2023 (+7.5%), $47.05 million in FY2022 (+1.1%) and $46.54 million in FY2021 (+47.7%).
- The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q3 2010.
- Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 69.2% in Q4 2024, against a decline of 11.9% in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.13 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.09 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.89 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.11 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.68 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.64 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.28 Bn |
| 10 | Kura Oncology | 695.52 Mn | -1.56 Bn | 22.47 Mn | 30.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 30.25 Mn |
| Jun 30, 2026 | 31.75 Mn |
| Mar 31, 2026 | 31.56 Mn |
| Dec 31, 2025 | 39.14 Mn |
| Sep 30, 2025 | 32.84 Mn |
| Jun 30, 2025 | 25.17 Mn |
| Mar 31, 2025 | 22.84 Mn |
| Dec 31, 2024 | 24.07 Mn |
| Sep 30, 2024 | 18.18 Mn |
| Jun 30, 2024 | 16.68 Mn |
| Mar 31, 2024 | 18.18 Mn |
| Dec 31, 2023 | 14.23 Mn |
| Sep 30, 2023 | 13.15 Mn |
| Jun 30, 2023 | 11.82 Mn |
| Mar 31, 2023 | 11.37 Mn |
| Dec 31, 2022 | 12.49 Mn |
| Sep 30, 2022 | 11.62 Mn |
| Jun 30, 2022 | 11.08 Mn |
| Mar 31, 2022 | 11.87 Mn |
| Dec 31, 2021 | 12.08 Mn |
API Access
Kura Oncology Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "KURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=KURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();